SCHEDULE OF DERIVATIVE LIABILITIES (Details) - USD ($)	9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Balance beginning of period – March 31	$ 759,065	$ 352,402
Derivative liabilities recognized pursuant to issuance of Series B preferred shares (Note 9)	642,417
Change in fair value of derivative liabilities	(142,830)	442,309
Reduction due to preferred shares converted	(119,359)	(53,036)
Balance end of period – December 31	1,139,293	741,675
Convertible Debt [Member]
Debt Instrument [Line Items]
Balance beginning of period – March 31	1,008,216	520,747
Change in fair value of derivative liabilities	386,845	27,662
Conversion to common shares	39,089	192,794
Convertible note modification		(53,402)
Balance end of period – December 31	928,333	351,719
New Issuance	1,224,933
Conversion to common shares	(39,089)	(192,794)
End of derivative treatment	$ (1,652,572)	$ (17,979)